Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Adipocyte-conditioned medium induces resistance of breast cancer cells to lapatinib

    The existence of a cross-talk between peritumoral adipocytes and cancer cells has been increasingly investigated. Several studies have shown that these adipocytes protect tumor cells from the effect of antican...

    A. Geneste, M. N. Duong, L. Molina, L. Conilh in BMC Pharmacology and Toxicology (2020)

  2. Article

    Open Access

    Host immune genetic variations influence the risk of develo** acute myeloid leukaemia: results from the NuCLEAR consortium

    The purpose of this study was to conduct a two-stage case control association study including 654 acute myeloid leukaemia (AML) patients and 3477 controls ascertained through the NuCLEAR consortium to evaluate...

    J. M. Sánchez-Maldonado, D. Campa, J. Springer, J. Badiola in Blood Cancer Journal (2020)

  3. No Access

    Article

    Monoclonal antibody therapy in multiple myeloma

    The therapeutic landscape of multiple myeloma (MM) has evolved spectacularly over the past decade with the discovery and validation of proteasome inhibitors and immunomodulatory agents as highly active agents,...

    C Touzeau, P Moreau, C Dumontet in Leukemia (2017)

  4. Article

    Erratum: Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case—control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

    Correction to: Leukemia (2012) 26, 1419–1422; doi:10.1038/leu.2011.352 Since the publication of this article the authors have noticed errors within the original text of the manuscript. Allele nomenclature of s...

    A Martino, D Campa, G Buda, J Sainz, R García-Sanz, K Jamroziak, R M Reis in Leukemia (2013)

  5. No Access

    Article

    Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case–control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium

    A Martino, D Campa, G Buda, J Sainz, R García-Sanz, K Jamroziak, R M Reis in Leukemia (2012)

  6. No Access

    Article

    Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains

    The spread of multiresistant bacteria increases the need for new antibiotics. The observation that some nucleoside analogues have antibacterial activity led us to further investigate the antimicrobial activity...

    A. Doléans-Jordheim, E. Bergeron in European Journal of Clinical Microbiology … (2011)

  7. No Access

    Article

    Genetic polymorphisms associated with outcome in multiple myeloma patients receiving high-dose melphalan

    High-dose melphalan (HDM) is an essential component in the treatment of patients with multiple myeloma (MM). Few data are available regarding genetic polymorphisms associated with patient outcome or toxicity i...

    C Dumontet, S Landi, T Reiman, T Perry, A Plesa, I Bellini in Bone Marrow Transplantation (2010)

  8. No Access

    Article

    Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues

    The clinical use of cytotoxic deoxynucleoside analogues is often limited by resistance mechanisms due to enzymatic deficiency, or high toxicity in nontumor tissues. To improve the use of these drugs, gene ther...

    C Hébrard, C Dumontet, L P Jordheim in Cancer Gene Therapy (2009)

  9. No Access

    Article

    Jatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy

    A phytochemical investigation of the aerial parts of Euphorbia spp., considered one of the most common elements of Mediterranean landascape, led to the isolation of a large number of bioactive plant metabolites, ...

    G. Corea, A. Di Pietro, C. Dumontet, E. Fattorusso, V. Lanzotti in Phytochemistry Reviews (2009)

  10. No Access

    Article

    A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells

    The zinc-finger protein A20/TNFAIP3, an inhibitor of nuclear factor-κB (NF-κB) activation, has been shown to protect MCF-7 breast carcinoma cells from TNFα-induced apoptosis. As estrogen receptor (ER) status is a...

    J A Vendrell, S Ghayad, S Ben-Larbi, C Dumontet, N Mechti, P A Cohen in Oncogene (2007)

  11. No Access

    Article

    Rituximab in CD20 positive multiple myeloma

    P Moreau, L Voillat, L Benboukher, C Mathiot, C Dumontet, N Robillard in Leukemia (2007)

  12. No Access

    Article

    Autoimmune thrombocytopenic purpura after autologous stem cell transplantation

    The pathogenesis of thrombocytopenia occurring after autologous stem cell transplantation (ASCT) remains unclear. Six cases of classical peripheral thrombocytopenia that developed after ASCT for non-Hodgkin's ...

    O Hequet, G Salles, N Ketterer, D Espinouse, C Dumontet in Bone Marrow Transplantation (2003)

  13. Article

    Open Access

    Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics

    In the present study, we compared the dynamics and composition of microtubules in cell lines derived from the human breast adenocarcinoma MCF-7 containing either the wild-type p53 (wt-p53; MN1) or a dominant-nega...

    C M Galmarini, K Kamath, A Vanier-Viornery, V Hervieu in British Journal of Cancer (2003)

  14. No Access

    Article

    Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma

    High-dose melphalan (HDM) has been adopted as standard therapy in the treatment of multiple myeloma. This treatment is associated with non-selective cytotoxicity, causing oral mucositis as the major non-hemato...

    C Thieblemont, C Dumontet, H Saad, N Roch, F Bouafia in Bone Marrow Transplantation (2002)

  15. No Access

    Article

    Identification and validation of seven genes, as potential markers, for the differential diagnosis of small B cell lymphomas (small lymphocytic lymphoma, marginal zone B cell lymphoma and mantle cell lymphoma) by cDNA macroarrays analysis

    C Thieblemont, K Chettab, P Felman, E Callet-Bauchu, A Traverse-Glehen in Leukemia (2002)

  16. No Access

    Article

    Multifocal progressive leukoencephalopathy occurring after refractory anemia and multiple infectious disorders consecutive to severe lymphopenia

    Progressive multifocal leukoencephalopathy (PML) is related to central nervous system infection with JC virus (JCV). This leukoencephalopathy occurs in immunocompromised patients such as those with acquired i...

    O. Hequet, G. Salles, D. Espinousse, C. Dumontet, F. Bouafia in Annals of Hematology (2002)

  17. No Access

    Article

    Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma

    Bone Marrow Transplantation (2002) 29, 544. doi:10.1038/sj.bmt.1703383

    O Hequet, C Dumontet, A El Jaafari-Corbin, G Salles in Bone Marrow Transplantation (2002)

  18. No Access

    Article

    Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters

    Cancer cell resistance to chemotherapy is often mediated by overexpression of P-glycoprotein, a plasma membrane ABC (ATP-binding cassette) transporter which extrudes cytotoxic drugs at the expense of ATP hydr...

    A. Di Pietro, G. Conseil, J.M. Pérez-Victoria in Cellular and Molecular Life Sciences CMLS (2002)

  19. Article

    Open Access

    Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity

    The present study was performed to gain insight into the role of p53 on the cytotoxicity of tubulin-binding agents (TBA) on cancer cells. Drug sensitivity, cell cycle distribution and drug-induced apoptosis we...

    C M Galmarini, N Falette, E Tabone, C Levrat, R Britten in British Journal of Cancer (2001)

  20. No Access

    Article

    Nucleoside analogues: mechanisms of drug resistance and reversal strategies

    Nucleoside analogues (NA) are essential components of AML induction therapy (cytosine arabinoside), effective treatments of lymphoproliferative disorders (fludarabine, cladribine) and are also used in the trea...

    CM Galmarini, JR Mackey, C Dumontet in Leukemia (2001)

previous disabled Page of 2